Company Overview of New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. develops prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe active pharmaceutical ingredients for therapeutic applications. It offers NHP-554C, an anti-platelet aspirin product for patients at higher risk for a secondary stroke/acute cardiac event that slowly releases into the bloodstream over 24 hours; NHP-554CZ, an anti-platelet aspirin product incorporating Yale University technology utilizing zinc salts; and NHP-229 for the purpose of lowering stomach acid alone or in combination with other drugs. The company was founded in 2008 and is based in New Haven, Connecticut.
142 Temple Street
New Haven, CT 06510
Founded in 2008
Key Executives for New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Key Developments
Similar Private Companies By Industry
|The Alliance for Clinical Trials in Oncology||United States|
|Alpha-Beta Technology||United States|
|Pioneer Surgical Orthobiologics Inc.||United States|
|Veeda Oncology||United States|
|CDG Therapeutics, Inc.||United States|
Recent Private Companies Transactions
April 25, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Tampa, FL | Bristol-Myers SquibbPosted: Nov 13
- New York, NY | RGPPosted: Oct 21
- Parsippany, NJ | RGPPosted: Nov 27
- Parsippany, NJ | RGPPosted: Oct 21
Sponsored Financial Commentaries
To contact New Haven Pharmaceuticals, Inc., please visit www.newhavenpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.